Physiomics (LON:PYC) Stock Price Up 4.9% – Should You Buy?

Physiomics Plc (LON:PYCGet Free Report)’s stock price was up 4.9% during mid-day trading on Thursday . The stock traded as high as GBX 0.58 and last traded at GBX 0.58. Approximately 4,705,372 shares were traded during trading, a decline of 35% from the average daily volume of 7,210,546 shares. The stock had previously closed at GBX 0.55.

Physiomics Trading Up 9.1%

The firm has a 50 day moving average price of GBX 0.48 and a 200-day moving average price of GBX 0.41. The firm has a market cap of £2.72 million, a price-to-earnings ratio of -4.00 and a beta of 0.95.

Physiomics (LON:PYCGet Free Report) last announced its earnings results on Monday, February 16th. The company reported GBX (0.10) earnings per share for the quarter. Physiomics had a negative net margin of 50.92% and a negative return on equity of 89.43%. As a group, equities analysts expect that Physiomics Plc will post -0.13 earnings per share for the current fiscal year.

Physiomics Company Profile

(Get Free Report)

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.

Read More

Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.